BSEM Stock Analysis
BS
Uncovered
Biostem Technologies Inc is uncovered by Eyestock quantitative analysis.
Market cap $B
0.009
Dividend yield
—
Shares outstanding
8.531 B
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. The company is headquartered in Pompano Beach, Florida. The company went IPO on 2001-07-11. The firm is focused on manufacturing products through its BioRetain processing method. BioRetain has been developed by applying the research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. The Company’s portfolio of brands includes VENDAJE, VENDAJE AC and VENDAJE OPTIC. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE AC is a structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds.